INDSWFTLAB — IND Swift Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual income statement for IND Swift Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10,387	12,073	12,809	5,617	6,491
Cost of Revenue
Gross Profit	4,245	4,572	5,311	2,389	3,239
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	9,600	10,535	6,793	3,801	6,439
Operating Profit	788	1,538	6,016	1,816	51.9
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	125	865	5,818	2,578	508
Provision for Income Taxes
Net Income After Taxes	-21.5	478	4,215	2,505	430
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	-21.5	476	4,210	2,505	431
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-21.5	476	4,210	2,505	431
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.364	10.5	23.6	0.796	6.96